日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Malaria vaccine protection against intradermal or venous parasites: a randomized phase 2b human challenge trial

疟疾疫苗对皮内或静脉寄生虫的保护作用:一项随机 2b 期人体挑战试验

Kapulu, Melissa C; Orenge, Francesca; Kimani, Domtila; Kibwana, Elizabeth; Kibet, Hillary; Mutahi, Mary; Datoo, Mehreen S; Bellamy, Duncan; Musembi, Janet; Ngoto, Omar; Rashid, Hamisi; Akinyi, Stellamaris; Mwatasa, Mwaganyuma H; Nyamako, Lydia; Keter, Kelvias; Gatheru, Rose; Mutiso, Agnes; Musyoki, Jennifer; Mwacharo, Jedidah; Abebe, Yonas; James, Eric R; Billingsley, Peter F; Ngetsa, Caroline; Mosobo, Moses; Makale, Johnstone; Tawa, Brian; Wamae, Kevin; Ochola-Oyier, Lynette I; Lawrie, Alison; Ramos-Lopez, Fernando; Roberts, Rachel; Richie, Thomas L; Sim, B Kim Lee; Hoffman, Stephen L; Ewer, Katie J; Hill, Adrian V S; Hamaluba, Mainga; Bejon, Philip

B and T cell responses to pre-erythrocytic R21/Matrix-M and blood-stage RH5.1/Matrix-M malaria vaccines in endemic settings.

在疟疾流行地区,B 细胞和 T 细胞对红细胞前 R21/Matrix-M 和血液期 RH5.1/Matrix-M 疟疾疫苗的反应。

Bundi Caroline K, Muñoz Olivia, Kibwana Elizabeth, Bellamy Duncan, Stockdale Lisa, Barrett Jordan R, McHugh Kirsty, Mtaka Ivanny, Kalinga Wilmina, Kimani Domtila, Nyamako Lydia, Keter Kelvias, Ogwang Rodney, Hill Adrian V S, Bejon Philip, Hamaluba Mainga, Silk Sarah E, Minassian Angela M, Draper Simon J, Olotu Ally I, Kapulu Melissa C, Ewer Katie J, Nielsen Carolyn M

Repertoire, function, and structure of serological antibodies induced by the R21/Matrix-M malaria vaccine

R21/Matrix-M疟疾疫苗诱导的血清抗体的种类、功能和结构

McDaniel, Jonathan R; Voss, William N; Bowyer, Georgina; Rush, Scott A; Spencer, Alexandra J; Bellamy, Duncan; Ulaszewska, Marta; Goike, Jule; Gregory, Scott; King, C Richter; McLellan, Jason S; Hill, Adrian V S; Georgiou, George; Ewer, Katie J; Ippolito, Gregory C

The anti-circumsporozoite antibody response to repeated, seasonal booster doses of the malaria vaccine RTS,S/AS01(E)

抗环子孢子抗体对疟疾疫苗RTS,S/AS01(E)的重复季节性加强剂量的反应

Ali, M Sanni; Stockdale, Lisa; Sagara, Issaka; Zongo, Issaka; Yerbanga, Rakiswendé Serge; Mahamar, Almahamoudou; Nikièma, Frédéric; Tapily, Amadou; Sompougdou, Frédéric; Diarra, Modibo; Bellamy, Duncan; Provstgaard-Morys, Samuel; Zoungrana, Charles; Issiaka, Djibrilla; Haro, Alassane; Sanogo, Koualy; Sienou, Abdoul Aziz; Kaya, Mahamadou; Traore, Seydou; Dicko, Oumar M; Kone, Youssouf; Yalcouye, Hama; Thera, Ismaila; Diarra, Kalifa; Snell, Paul; Ofori-Anyinam, Opokua; Ockenhouse, Chris; Lee, Cynthia; Ewer, Katie; Tinto, Halidou; Djimde, Abdoulaye; Ouedraogo, Jean-Bosco; Dicko, Alassane; Chandramohan, Daniel; Greenwood, Brian

R21/Matrix-M malaria vaccine drives diverse immune responses in pre-exposed adults: insights from a phase IIb controlled human malaria infection trial

R21/Matrix-M疟疾疫苗在既往感染过疟疾的成年人中诱发多种免疫反应:一项IIb期对照人体疟疾感染试验的启示

Kibwana, Elizabeth; Bundi, Caroline; Kimani, Domtila; Nyamako, Lydia; Keter, Kelvias; Mutiso, Agnes; Ogwang, Rodney; Bellamy, Duncan; Rapi, Katerina; Bajer, Amelia; Provstgaard-Morys, Samuel; Stockdale, Lisa; Munoz, Olivia; Datoo, Mehreen S; Lawrie, Alison; Ramos-Lopez, Fernando; Roberts, Rachel; Hamaluba, Mainga; Hill, Adrian V S; Bejon, Philip; Ewer, Katie J; Kapulu, Melissa

Phase I/IIa study to assess the safety, immunogenicity and efficacy of ChAdOx1-MVA vectored vaccines expressing a novel liver-stage malaria dual antigen LS2 by sporozoite challenge in malaria-naïve adults

一项 I/IIa 期研究旨在评估 ChAdOx1-MVA 载体疫苗(表达一种新型肝期疟疾双抗原 LS2)在未感染过疟疾的成年人中通过孢子攻击的安全性、免疫原性和有效性。

Silman, Daniel; Flaxman, Amy; Datoo, Mehreen; Edwards, Nick J; Ramos-Lopez, Fernando; Mitton, Celia; Mair, Catherine; Bellamy, Duncan; Bowyer, Georgina; Morter, Richard; Halbroth, Benedict; Venkatraman, Navin; Folegatti, Pedro M; Marshall, Julia; Poulton, Ian; Bajer, Amelia; Salman, Ahmed M; Berrie, Eleanor; Baum, Jake; Blagborough, Andrew M; Crocker, Wendy; Roberts, Rachel; Lawrie, Alison M; Spencer, Alexandra J; Gilbert, Sarah C; Ewer, Katie J; Hill, Adrian V S

Correlations between three ELISA protocols measurements of RTS,S/AS01-induced anti-CSP IgG antibodies

三种ELISA方法测定RTS,S/AS01诱导的抗CSP IgG抗体的相关性

Mugo, Robert M; Orindi, Benedict; Shee, Faiz M; Bellamy, Duncan; Mwacharo, Jedidah; Ewer, Katie J; Bejon, Philip; Ndungu, Francis M

Safety and immunogenicity of varied doses of R21/Matrix-M™ vaccine at three years follow-up: A phase 1b age de-escalation, dose-escalation trial in adults, children, and infants in Kilifi-Kenya

R21/Matrix-M™疫苗不同剂量在三年随访中的安全性和免疫原性:一项在肯尼亚基利菲进行的成人、儿童和婴儿的1b期年龄递减、剂量递增试验

Sang, Samuel; Datoo, Mehreen S; Otieno, Edward; Muiruri, Charles; Bellamy, Duncan; Gathuri, Emmaloise; Ngoto, Omar; Musembi, Janet; Provstgaard-Morys, Sam; Stockdale, Lisa; Aboagye, Jeremy; Woods, Daniel; Lawrie, Alison; Roberts, Racheal; Keter, Kelvias; Kimani, Domtila; Ndungu, Francis; Kapulu, Melissa; Njau, Irene; Orindi, Benedict; Ewer, Katie J; Hill, Adrian V S; Bejon, Philip; Hamaluba, Mainga

Safety and immunogenicity of a simian-adenovirus-vectored rabies vaccine: an open-label, non-randomised, dose-escalation, first-in-human, single-centre, phase 1 clinical trial

猴腺病毒载体狂犬病疫苗的安全性和免疫原性:一项开放标签、非随机、剂量递增、首次人体试验、单中心、I期临床试验

Jenkin, Daniel; Ritchie, Adam J; Aboagye, Jeremy; Fedosyuk, Sofiya; Thorley, Luke; Provstgaad-Morys, Samuel; Sanders, Helen; Bellamy, Duncan; Makinson, Rebecca; Xiang, Zhi Quan; Bolam, Emma; Tarrant, Richard; Ramos Lopez, Fernando; Platt, Abigail; Poulton, Ian; Green, Catherine; Ertl, Hildegund C J; Ewer, Katie J; Douglas, Alexander D

Harmonization and qualification of intracellular cytokine staining to measure influenza-specific CD4(+) T cell immunity within the FLUCOP consortium

FLUCOP联盟内用于测量流感特异性CD4(+) T细胞免疫的细胞内细胞因子染色方法的协调和鉴定

Begue, Sarah; Waerlop, Gwenn; Salaun, Bruno; Janssens, Michel; Bellamy, Duncan; Cox, Rebecca Jane; Davies, Richard; Gianchecchi, Elena; Medaglini, Donata; Montomoli, Emanuele; Pettini, Elena; Leroux-Roels, Geert; Clement, Frédéric; Pagnon, Anke